The findings of the present study indicated that CA 19-9 levels were associated with higher sensitivity, DOR, and AUC compared with the corresponding levels of CEA with regard to the diagnosis of pancreatic cancer. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.